Type 2 diabetes mellitus and fracture risk

Metabolism: Clinical and Experimental

Volumn 63, Issue 12, 2014, Pages 1480-1490

  Dede, Anastasia D ^a   Tournis, Symeon ^b   Dontas, Ismene ^b   Trovas, George ^b  

^a HIPPOKRATION HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Advanced glycation end products; Bone fragility; Collagen cross linking; Diabetes; Fracture healing

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIDIABETIC AGENT; DRUG THERAPY; PHARMACOLOGY;

ANIMAL; BONE; BONE DENSITY; BONE FRAGILITY; BONE STRENGTH; BONE TURNOVER; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC PATIENT; EPIDEMIOLOGY; FRACTURE; FRACTURE HEALING; FRACTURES, BONE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK; RISK ASSESSMENT; RISK FACTOR; SPINE FRACTURE;

ANIMALS; BONE AND BONES; COMPLICATIONS; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; FRACTURES, BONE; HUMANS; HYPOGLYCEMIC AGENTS; METABOLISM; PHARMACOLOGY; RISK; THERAPEUTIC USE;

EID: 84964240667     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.09.002     Document Type: Review

References (105)

1. International Diabetes Federation IDF Diabetes Atlas 6th edn 2013 International Diabetes Federation Brussels, Belgium [ http://www.idf.org/diabetesatlas ]
2. J.E. Shaw, R.A. Sicree, and P.Z. Zimmet Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Res Clin Pract 87 1 2010 4 14
3. M. Janghorbani, D. Feskanich, W.C. Willett, and F. Hu Prospective study of diabetes and risk of hip fracture: the Nurses' Health Study Diabetes Care 29 7 2006 1573 1578
4. D.E. Bonds, J.C. Larson, A.V. Schwartz, E.S. Strotmeyer, J. Robbins, and B.L. Rodriguez Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study J Clin Endocrinol Metab 91 9 2006 3404 3410
5. I.I. de Liefde, M. van der Klift, C.E. de Laet, P.L. van Daele, A. Hofman, and H.A. Pols Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study Osteoporos Int 16 12 2005 1713 1720
6. L.J. Melton III, C.L. Leibson, S.J. Achenbach, T.M. Therneau, and S. Khosla Fracture risk in type 2 diabetes: update of a population-based study J Bone Miner Res 23 8 2008 1334 1342
7. P. Vestergaard, L. Rejnmark, and L. Mosekilde Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk Diabetologia 48 7 2005 1292 1299
8. M. Janghorbani, R.M. Van Dam, W.C. Willett, and F.B. Hu Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture Am J Epidemiol 166 5 2007 495 505
9. M. Yamamoto, T. Yamaguchi, M. Yamauchi, H. Kaji, and T. Sugimoto Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications J Bone Miner Res 24 4 2009 702 709
10. R.Q. Ivers, R.G. Cumming, P. Mitchell, A.J. Peduto, and Blue Mountains Eye Study Diabetes and risk of fracture: the Blue Mountains Eye Study Diabetes Care 24 7 2001 1198 1203
11. W.D. Leslie, L.M. Lix, H.J. Prior, S. Derksen, C. Metge, and J. O'Neil Biphasic fracture risk in diabetes: a population-based study Bone 40 6 2007 1595 1601
12. A.V. Schwartz, T.A. Hillier, D.E. Sellmeyer, H.E. Resnick, E. Gregg, and K.E. Ensrud Older women with diabetes have a higher risk of falls: a prospective study Diabetes Care 25 10 2002 1749 1754
13. E.W. Gregg, G.L. Beckles, D.F. Williamson, S.G. Leveille, J.A. Langlois, and M.M. Engelgau Diabetes and physical disability among older U.S. adults Diabetes Care 23 9 2000 1272 1277
14. A. Malmivaara, M. Heliövaara, P. Knekt, A. Reunanen, and A. Aromaa Risk factors for injurious falls leading to hospitalization or death in a cohort of 19,500 adults Am J Epidemiol 138 6 1993 384 394
15. S.S. Johnston, C. Conner, M. Aagren, K. Ruiz, and J. Bouchard Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes Diabetes Obes Metab 14 7 2012 634 643
16. P. Vestergaard, L. Rejnmark, and L. Mosekilde Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes Calcif Tissue Int 84 1 2009 45 55
17. L. Oei, M.C. Zillikens, A. Dehghan, G.H. Buitendijk, M.C. Castaño-Betancourt, and K. Estrada High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study Diabetes Care 36 6 2013 1619 1628
18. A.V. Schwartz, K.L. Margolis, D.E. Sellmeyer, E. Vittinghoff, W.T. Ambrosius, and D.E. Bonds Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial Diabetes Care 35 7 2012 1525 1531
19. A. Diez-Perez, R. Güerri, X. Nogues, E. Cáceres, M.J. Peña, and L. Mellibovsky Microindentation for in vivo measurement of bone tissue mechanical properties in humans J Bone Miner Res 25 8 2010 1877 1885
20. G. Zoppini, A. Galletti, G. Targher, C. Brangani, I. Pichiri, and C. Negri Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients PLoS One 8 12 2013 e82733
21. Y.J. Kim, S.O. Park, T.H. Kim, J.H. Lee, and S.H. Kim The association of serum 25-hydroxyvitamin D and vertebral fractures in patients with type 2 diabetes Endocr J 60 2 2013 179 184
22. L. Ma, L. Oei, L. Jiang, K. Estrada, H. Chen, and Z. Wang Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies Eur J Epidemiol 27 5 2012 319 332
23. J.C. Krakauer, M.J. McKenna, N.F. Buderer, D.S. Rao, F.W. Whitehouse, and A.M. Parfitt Bone loss and bone turnover in diabetes Diabetes 44 7 1995 775 782
24. A.V. Schwartz, D.E. Sellmeyer, E.S. Strotmeyer, F.A. Tylavsky, K.R. Feingold, and H.E. Resnick Diabetes and bone loss at the hip in older black and white adults J Bone Miner Res 20 4 2005 596 603
25. E.W. Lipkin, A.V. Schwartz, A.M. Anderson, C. Davis, K.C. Johnson, and E.W. Gregg Bone loss at four-year follow-up in type 2 diabetes Diabetes Care 37 10 2014 2822 2829 [pii: DC-140762]
26. F. Gregorio, S. Cristallini, F. Santeusanio, P. Filipponi, and P. Fumelli Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Res Clin Pract 23 1 1994 43 54
27. A. Shu, M.T. Yin, E. Stein, S. Cremers, E. Dworakowski, and R. Ives Bone structure and turnover in type 2 diabetes mellitus Osteoporos Int 23 2 2012 635 641
28. J.N. Farr, M.T. Drake, S. Amin, L.J. Melton III, L.K. McCready, and S. Khosla In Vivo assessment of bone quality in postmenopausal women with type 2 diabetes J Bone Miner Res 29 4 2014 787 795
29. J. Starup-Linde, S.A. Eriksen, S. Lykkeboe, A. Handberg, and P. Vestergaard Biochemical markers of bone turnover in diabetes patients-a meta-analysis, and a methodological study on the effects of glucose on bone markers Osteoporos Int 25 6 2014 1697 1708
30. A. García-Martín, P. Rozas-Moreno, R. Reyes-García, S. Morales-Santana, B. García-Fontana, and J.A. García-Salcedo Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus J Clin Endocrinol Metab 97 1 2012 234 241
31. M.S. Ardawi, D.H. Akhbar, A. Alshaikh, M.M. Ahmed, M.H. Qari, and A.A. Rouzi Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes Bone 56 2 2013 355 362
32. R.J. Fajardo, L. Karim, V.I. Calley, and M.L. Bouxsein a review of rodent models of type 2 diabetic skeletal fragility J Bone Miner Res 29 5 2014 1025 1040
33. M.A. Petit, M.L. Paudel, B.C. Taylor, J.M. Hughes, E.S. Strotmeyer, and A.V. Schwartz Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study J Bone Miner Res 25 2 2010 285 291
34. S.W. Park, B.H. Goodpaster, E.S. Strotmeyer, N. de Rekeneire, T.B. Harris, and A.V. Schwartz Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study Diabetes 55 6 2006 1813 1818
35. A.J. Burghardt, A.S. Issever, A.V. Schwartz, K.A. Davis, U. Masharani, and S. Majumdar High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus J Clin Endocrinol Metab 95 11 2010 5045 5055
36. J.M. Patsch, A.J. Burghardt, S.P. Yap, T. Baum, A.V. Schwartz, and G.B. Joseph Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures J Bone Miner Res 28 2 2013 313 324
37. S. Ishii, J.A. Cauley, C.J. Crandall, P. Srikanthan, G.A. Greendale, and M.H. Huang Diabetes and femoral neck strength: findings from the Hip Strength Across the Menopausal Transition Study J Clin Endocrinol Metab 97 1 2012 190 197
38. R. Garg, Z. Chen, T. Beck, J.A. Cauley, G. Wu, and D. Nelson Hip geometry in diabetic women: implications for fracture risk Metabolism 61 12 2012 1756 1762
39. D. Hans, A.L. Goertzen, M.A. Krieg, and W.D. Leslie Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study J Bone Miner Res 26 11 2011 2762 2769
40. W.D. Leslie, B. Aubry-Rozier, O. Lamy, and D. Hans Manitoba Bone Density Program. TBS (trabecular bone score) and diabetes-related fracture risk J Clin Endocrinol Metab 98 2 2013 602 609
41. R. Dhaliwal, D. Cibula, C. Ghosh, R.S. Weinstock, and A.M. Moses Bone quality assessment in type 2 diabetes mellitus Osteoporos Int 25 7 2014 1969 1973
42. P. Hansma, H. Yu, D. Schultz, A. Rodriguez, E.A. Yurtsev, and J. Orr The tissue diagnostic instrument Rev Sci Instrum 80 5 2009 054303
43. J.M. Pritchard, A. Papaioannou, C. Tomowich, L.M. Giangregorio, S.A. Atkinson, and K.A. Beattie Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone Bone 54 1 2013 76 82
44. S.Y. Tang, U. Zeenath, and D. Vashishth Effects of non-enzymatic glycation on cancellous bone fragility Bone 40 4 2007 1144 1151
45. D. Vashishth, G.J. Gibson, J.I. Khoury, M.B. Schaffler, J. Kimura, and D.P. Fyhrie Influence of nonenzymatic glycation on biomechanical properties of cortical bone Bone 28 2 2001 195 201
46. S.Y. Tang, and D. Vashishth Non-enzymatic glycation alters microdamage formation in human cancellous bone Bone 46 1 2010 148 154
47. K. Okazaki, T. Yamaguchi, K. Tanaka, M. Notsu, N. Ogawa, and S. Yano Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis Calcif Tissue Int 91 4 2012 286 296
48. R. Sanguineti, D. Storace, F. Monacelli, A. Federici, and P. Odetti Pentosidine effects on human osteoblasts in vitro Ann N Y Acad Sci 1126 2008 166 172
49. M. Alikhani, Z. Alikhani, C. Boyd, C.M. MacLellan, M. Raptis, and R. Liu Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways Bone 40 2 2007 345 353
50. U. Valcourt, B. Merle, E. Gineyts, S. Viguet-Carrin, P.D. Delmas, and P. Garnero Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation J Biol Chem 282 8 2007 5691 5703
51. X.N. Dong, A. Qin, J. Xu, and X. Wang In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption Bone 49 2 2011 174 183
52. L. Vanella, D.H. Kim, D. Asprinio, S.J. Peterson, I. Barbagallo, and A. Vanella HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage Bone 46 1 2010 236 243
53. M. Terada, M. Inaba, Y. Yano, T. Hasuma, Y. Nishizawa, and H. Morii Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells Bone 22 1 1998 17 23
54. M. Arai, Y. Shibata, K. Pugdee, Y. Abiko, and Y. Ogata Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells IUBMB Life 59 1 2007 27 33
55. Y. Hamada, S. Kitazawa, R. Kitazawa, H. Fujii, M. Kasuga, and M. Fukagawa Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress Bone 40 5 2007 1408 1414
56. P. Odetti, S. Rossi, F. Monacelli, A. Poggi, M. Cirnigliaro, and M. Federici Advanced glycation end products and bone loss during aging Ann N Y Acad Sci 1043 2005 710 717
57. S. Viguet-Carrin, J.P. Roux, M.E. Arlot, Z. Merabet, D.J. Leeming, and I. Byrjalsen Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae Bone 39 5 2006 1073 1079
58. M. Saito, K. Fujii, S. Soshi, and T. Tanaka Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture Osteoporos Int 17 7 2006 986 995
59. S. Tanaka, T. Kuroda, M. Saito, and M. Shiraki Urinary pentosidine improves risk classification using fracture risk assessment tools for postmenopausal women J Bone Miner Res 26 11 2011 2778 2784
60. M. Yamamoto, T. Yamaguchi, M. Yamauchi, S. Yano, and T. Sugimoto Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes J Clin Endocrinol Metab 93 3 2008 1013 1019
61. A.V. Schwartz, P. Garnero, T.A. Hillier, D.E. Sellmeyer, E.S. Strotmeyer, and K.R. Feingold Pentosidine and increased fracture risk in older adults with type 2 diabetes J Clin Endocrinol Metab 94 7 2009 2380 2386
62. B. Lecka-Czernik, E.J. Moerman, D.F. Grant, J.M. Lehmann, S.C. Manolagas, and R.L. Jilka Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation Endocrinology 143 6 2002 2376 2384
63. G. Mabilleau, A. Mieczkowska, and M.E. Edmonds Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression Diabet Med 27 8 2010 925 932
64. M.A. Sorocéanu, D. Miao, X.Y. Bai, H. Su, D. Goltzman, and A.C. Karaplis Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis J Endocrinol 183 1 2004 203 216
65. A.V. Schwartz, D.E. Sellmeyer, E. Vittinghoff, L. Palermo, B. Lecka-Czernik, and K.R. Feingold Thiazolidinedione use and bone loss in older diabetic adults J Clin Endocrinol Metab 91 9 2006 3349 3354
66. D. Glintborg, M. Andersen, C. Hagen, L. Heickendorff, and A.P. Hermann Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial J Clin Endocrinol Metab 93 5 2008 1696 1701
67. S. Yaturu, B. Bryant, and S.K. Jain Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men Diabetes Care 30 6 2007 1574 1576
68. D. Bilik, L.N. McEwen, M.B. Brown, N.E. Pomeroy, C. Kim, and K. Asao Thiazolidinediones and fractures: evidence from translating research into action for diabetes J Clin Endocrinol Metab 95 10 2010 4560 4565
69. C.R. Dormuth, G. Carney, B. Carleton, K. Bassett, and J.M. Wright Thiazolidinediones and fractures in men and women Arch Intern Med 169 15 2009 1395 1402
70. I. Kanazawa, T. Yamaguchi, M. Yamamoto, and T. Sugimoto Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus J Bone Miner Metab 28 5 2010 554 560
71. P. Ma, B. Gu, J. Ma, L. E, X. Wu, and J. Cao Glimepiride induces proliferation and differentiation of rat osteoblasts via the PI3-kinase/Akt pathway Metabolism 59 3 2010 359 366
72. A.M. Cortizo, C. Sedlinsky, A.D. McCarthy, A. Blanco, and L. Schurman Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture Eur J Pharmacol 536 1-2 2006 38 46
73. Q.G. Mai, Z.M. Zhang, S. Xu, M. Lu, R.P. Zhou, and L. Zhao Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats J Cell Biochem 112 10 2011 2902 2909
74. C. Sedlinsky, M.S. Molinuevo, A.M. Cortizo, M.J. Tolosa, J.I. Felice, and M.L. Sbaraglini Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats Eur J Pharmacol 668 3 2011 477 485
75. J.L. Borges, J.P. Bilezikian, A.R. Jones-Leone, A.P. Acusta, P.D. Ambery, and A.J. Nino A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 diabetes mellitus patients Diabetes Obes Metab 13 11 2011 1036 1046
76. L. Schurman, A.D. McCarthy, C. Sedlinsky, M.V. Gangoiti, V. Arnol, and L. Bruzzone Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells Exp Clin Endocrinol Diabetes 116 6 2008 333 340
77. M.P. Yavropoulou, and J.G. Yovos Incretins and bone: evolving concepts in nutrient-dependent regulation of bone turnover Hormones (Athens) 12 2 2013 214 223
78. M.C. Bunck, B. Eliasson, A. Cornér, R.J. Heine, R.M. Shaginian, and M.R. Taskinen Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes Diabetes Obes Metab 13 4 2011 374 377
79. G. Mabilleau, A. Mieczkowska, and D. Chappard Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials J Diabetes 6 3 2014 260 266
80. R.J. Bollag, Q. Zhong, and P. Phillips Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors Endocrinology 141 3 2000 1228 1235
81. I.P. Wong, P.A. Baldock, and H. Herzog Gastrointestinal peptides and bone health Curr Opin Endocrinol Diabetes Obes 17 1 2010 44 50
82. D.B. Henriksen, P. Alexandersen, B. Hartmann, C.L. Adrian, I. Byrjalsen, and H.G. Bone Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women Bone 40 3 2007 723 729
83. D.B. Henriksen, P. Alexandersen, B. Hartmann, C.L. Adrian, I. Byrjalsen, and H.G. Bone Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD Bone 45 5 2009 833 842
84. K.A. Kyle, T.L. Willett, L.L. Baggio, D.J. Drucker, and M.D. Grynpas Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice Endocrinology 152 2 2011 457 467
85. J.H.M. Driessen, H.A.W. van Onzenoort, R.M.A. Henry, A. Lalmohamed, J.P. van den Bergh, and C. Neef Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture Bone 2014 10.1016/j.bone.2014.07.030 [Epub ahead of print]
86. M. Monami, I. Dicembrini, A. Antenore, and E. Mannucci Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials Diabetes Care 34 11 2011 2474 2476
87. Ö. Ljunggren, J. Bolinder, L. Johansson, J. Wilding, A.M. Langkilde, and C.D. Sjöström Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin Diabetes Obes Metab 14 11 2012 990 999
88. A.K. Borm, M.S. Klevesath, V. Borcea, C. Kasperk, M.J. Seibel, and P. Wahl The effect of pramlintide (amylin analogue) treatment on bone metabolism and bone density in patients with type 1 diabetes mellitus Horm Metab Res 31 8 1999 472 475
89. A.V. Schwartz, E. Vittinghoff, D.C. Bauer, T.A. Hillier, E.S. Strotmeyer, and K.E. Ensrud Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes JAMA 305 21 2011 2184 2192
90. L.M. Giangregorio, W.D. Leslie, L.M. Lix, H. Johansson, A. Oden, and E. McCloskey FRAX underestimates fracture risk in patients with diabetes J Bone Miner Res 27 2 2012 301 308
91. W.D. Leslie, S.N. Morin, L.M. Lix, and S.R. Majumdar Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture? Osteoporos Int 2014 10.1007/s00198-014-2822-2 [Epub ahead of print]
92. J.A. Kanis, E.V. McCloskey, H. Johansson, C. Cooper, R. Rizzoli, and J.Y. Reginster Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 24 1 2013 23 57
93. P. Vestergaard, L. Rejnmark, and L. Mosekilde Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif Tissue Int 88 3 2011 209 214
94. O. Johnell, J.A. Kanis, D.M. Black, A. Balogh, G. Poor, and S. Sarkar Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study J Bone Miner Res 19 5 2004 764 772
95. T.H. Keegan, A.V. Schwartz, D.C. Bauer, D.E. Sellmeyer, and J.L. Kelsey Fracture intervention trial. Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial Diabetes Care 27 7 2004 1547 1553
96. K.E. Ensrud, J.L. Stock, E. Barrett-Connor, D. Grady, L. Mosca, and K.T. Khaw Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial J Bone Miner Res 23 1 2008 112 120
97. A.V. Schwartz, A.L. Schafer, A. Grey, E. Vittinghoff, L. Palermo, and L.Y. Lui Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials J Bone Miner Res 28 6 2013 1348 1354
98. R.K. Hernandez, T.P. Do, C.W. Critchlow, R.E. Dent, and S.S. Jick Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database Acta Orthop 83 6 2012 653 660
99. D.K. Wukich, A. Joseph, M. Ryan, C. Ramirez, and J.J. Irrgang Outcomes of ankle fractures in patients with uncomplicated versus complicated diabetes Foot Ankle Int 32 2 2011 120 130
100. N. Shibuya, J.M. Humphers, B.L. Fluhman, and D.C. Jupiter Factors associated with nonunion, delayed union, and malunion in foot and ankle surgery in diabetic patients J Foot Ankle Surg 52 2 2013 207 211
101. S.P. Ganesh, R. Pietrobon, W.A. Cecílio, D. Pan, N. Lightdale, and J.A. Nunley The impact of diabetes on patient outcomes after ankle fracture J Bone Joint Surg Am 87 8 2005 1712 1718
102. H. Wang, Y.W. Lü, L. Lan, Q. Zhang, H.L. Chen, and G.Y. Zhang Impact of diabetes on the prognosis of hip fracture: a cohort study in the Chinese population Chin Med J (Engl) 126 5 2013 813 818
103. M. Retzepi, and N. Donos The effect of diabetes mellitus on osseous healing Clin Oral Implants Res 21 7 2010 673 681
104. G.E. Umpierrez, R. Hellman, M.T. Korytkowski, M. Kosiborod, G.A. Maynard, and V.M. Montori Endocrine Society. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline J Clin Endocrinol Metab 97 1 2012 16 38
105. G. Gómez-Moreno, A. Aguilar-Salvatierra, J. Rubio Roldán, J. Guardia, J. Gargallo, and J.L. Calvo-Guirado Peri-implant evaluation in type 2 diabetes mellitus patients: a 3-year study Clin Oral Implants Res 2014 10.1111/clr.12391 [Epub ahead of print]